Jane Street’s Immunogen Inc IMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-742,100
Closed -$22M 10411
2023
Q4
$22M Buy
742,100
+527,100
+245% +$10.5M 0.01% 1190
2023
Q3
$3.41M Sell
215,000
-183,800
-46% -$3.06M ﹤0.01% 3173
2023
Q2
$7.53M Buy
398,800
+284,500
+249% +$3.36M ﹤0.01% 2225
2023
Q1
$439K Buy
114,300
+23,400
+26% +$99.7K ﹤0.01% 6535
2022
Q4
$451K Buy
90,900
+19,900
+28% +$108K ﹤0.01% 6316
2022
Q3
$339K Sell
71,000
-44,800
-39% -$236K ﹤0.01% 7381
2022
Q2
$521K Buy
115,800
+24,600
+27% +$107K ﹤0.01% 6664
2022
Q1
$434K Sell
91,200
-248,300
-73% -$1.37M ﹤0.01% 7741
2021
Q4
$2.52M Buy
339,500
+122,500
+56% +$761K ﹤0.01% 4017
2021
Q3
$1.23M Buy
217,000
+126,300
+139% +$730K ﹤0.01% 5500
2021
Q2
$598K Buy
90,700
+27,500
+44% +$192K ﹤0.01% 6909
2021
Q1
$512K Buy
63,200
+36,600
+138% +$299K ﹤0.01% 6761
2020
Q4
$172K Buy
26,600
+3,100
+13% +$18.1K ﹤0.01% 7023
2020
Q3
$85K Buy
23,500
+13,200
+128% +$53.3K ﹤0.01% 6796
2020
Q2
$47K Buy
+10,300
New +$43.8K ﹤0.01% 6878
2018
Q3
Sell
-11,100
Closed -$108K 5855
2018
Q2
$108K Buy
+11,100
New +$117K ﹤0.01% 4718
2017
Q4
Sell
-38,300
Closed -$293K 5316
2017
Q3
$293K Buy
+38,300
New +$254K ﹤0.01% 3721

Other funds holding IMGN

Jane Street's IMGN Position: Q1 2024 in Review

Jane Street sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 634,353 shares — an estimated $18.8M sold.

Jane Street first reported a position in IMGN in Q2 2013 and held it in 29 quarters. The position peaked at $18.8M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Jane Street reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Jane Street sold 634,353 Immunogen Inc shares in Q1 2024, an estimated $18.8M.
  • Jane Street first reported a position in Immunogen Inc in Q2 2013 and held it in 29 quarters.
  • Jane Street's Immunogen Inc position peaked at $18.8M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Jane Street's 13F filing for Q1 2024, filed 16 May 2024.